총 165페이지
163페이지 본문시작
참고자료
Sharun K, Dhama K, Tiwari R, Gugjoo MB, Iqbal Yatoo M, Patel SK, Pathak
M, Karthik K, Khurana SK, Singh R, Puvvala B, Amarpal, Singh R, Singh KP,
Chaicumpa W. Advances in therapeutic and managemental approaches of
bovine mastitis. Vet Q. 2021. 41:107-136.
Smith GW, Constable PD, Morin DE. Ability of hematologic and serum
biochemical variables to differentiate Gram-negative and Gram-positive
mastitis in dairy cows. J Vet Intern Med. 2001. 15:394-400.
Smith KLD, Todhunter DA and Schoenberger PS. Environmental mastitis : Cause,
prevalence, prevention. J Dairy Sci. 1985. 68:1531.
Sordillo L. Factors affecting mammary gland immunity and mastitis
susceptibility. Livestock Prod Sci. 2005. 98:89-99.
Suojala L, Kaartinen L, Pyorala S. Treatment for bovine Escherichia coli mastitis
- an evidence-based approach. J Vet Pharmacol Ther. 2013. 36:521-531.
Taponen S, Jantunen A, Pyorala E, Pyorala S. Efficacy of targeted 5-day parenteral
and intramammary treatment of clinical bovine Staphylococcus aureus mastitis
caused by penicillin-susceptible or penicillin-resistant bacterial isolate. Acta
Vet Scand. 2003. 44:53-62.
Taponen S, Pyorala S. Coagulase-negative staphylococci as cause of bovine
mastitis-not so different from Staphylococcus aureus? Vet Microbiol. 2009.
16;134(1-2):29-36.
Thompson PD, Pearson RE. Likelihood of droplet impacts on teat ends during
induced milking vacuum fluctuations. J Dairy Sci. 1979. 62:1314.
Thompson PD, Schultze WD, Sauls JN, Arapis SC. Mastitis infection from abrupt
loss of milking vacuum. J Dairy Sci. 1978. 61:344.
US food and drug administration. NARMS now: integrated data. Available at:
https://www.fda.gov/animal-veterinary/national-antimicrobial-resistance-m
onitoring-system/narms-now-integrated-data. 2021
Watts JL. Etiological agents of bovine mastitis. Vet Microbiol. 1988. 16:41-66.
157
Sharun K, Dhama K, Tiwari R, Gugjoo MB, Iqbal Yatoo M, Patel SK, Pathak
M, Karthik K, Khurana SK, Singh R, Puvvala B, Amarpal, Singh R, Singh KP,
Chaicumpa W. Advances in therapeutic and managemental approaches of
bovine mastitis. Vet Q. 2021. 41:107-136.
Smith GW, Constable PD, Morin DE. Ability of hematologic and serum
biochemical variables to differentiate Gram-negative and Gram-positive
mastitis in dairy cows. J Vet Intern Med. 2001. 15:394-400.
Smith KLD, Todhunter DA and Schoenberger PS. Environmental mastitis : Cause,
prevalence, prevention. J Dairy Sci. 1985. 68:1531.
Sordillo L. Factors affecting mammary gland immunity and mastitis
susceptibility. Livestock Prod Sci. 2005. 98:89-99.
Suojala L, Kaartinen L, Pyorala S. Treatment for bovine Escherichia coli mastitis
- an evidence-based approach. J Vet Pharmacol Ther. 2013. 36:521-531.
Taponen S, Jantunen A, Pyorala E, Pyorala S. Efficacy of targeted 5-day parenteral
and intramammary treatment of clinical bovine Staphylococcus aureus mastitis
caused by penicillin-susceptible or penicillin-resistant bacterial isolate. Acta
Vet Scand. 2003. 44:53-62.
Taponen S, Pyorala S. Coagulase-negative staphylococci as cause of bovine
mastitis-not so different from Staphylococcus aureus? Vet Microbiol. 2009.
16;134(1-2):29-36.
Thompson PD, Pearson RE. Likelihood of droplet impacts on teat ends during
induced milking vacuum fluctuations. J Dairy Sci. 1979. 62:1314.
Thompson PD, Schultze WD, Sauls JN, Arapis SC. Mastitis infection from abrupt
loss of milking vacuum. J Dairy Sci. 1978. 61:344.
US food and drug administration. NARMS now: integrated data. Available at:
https://www.fda.gov/animal-veterinary/national-antimicrobial-resistance-m
onitoring-system/narms-now-integrated-data. 2021
Watts JL. Etiological agents of bovine mastitis. Vet Microbiol. 1988. 16:41-66.
157
163페이지 본문끝
메뉴
현재 포커스의 아래내용들은 동일한 컨텐츠를 가지고 페이지넘김 효과및 시각적 효과를 제공하는 페이지이므로 스크린리더 사용자는 여기까지만 낭독하시고 위의 페이지이동 링크를 사용하여 다음페이지로 이동하시기 바랍니다.